Fig. 1From: Carboplatin versus cisplatin in combination with etoposide in the first-line treatment of small cell lung cancer: a pooled analysisThe progression-free survival (A) and overall survival (B) of patients with extensive-stage small-cell lung cancer according to the treatment groupsBack to article page